Rxo Inc (NYSE:RXO – Get Free Report) Director Thomas Szlosek purchased 20,308 shares of RXO stock in a transaction that occurred on Friday, November 7th. The shares were bought at an average price of $12.37 per share, for a total transaction of $251,209.96. Following the transaction, the director directly owned 36,508 shares of the company’s stock, valued at $451,603.96. This trade represents a 125.36% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
RXO Stock Up 7.4%
Shares of RXO stock traded up $0.91 during trading on Wednesday, hitting $13.09. The company’s stock had a trading volume of 360,171 shares, compared to its average volume of 1,740,056. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.32 and a current ratio of 1.32. The company has a fifty day simple moving average of $16.53 and a two-hundred day simple moving average of $16.04. Rxo Inc has a 52 week low of $11.37 and a 52 week high of $31.11. The company has a market capitalization of $2.15 billion, a PE ratio of -30.45, a P/E/G ratio of 18.21 and a beta of 1.67.
RXO (NYSE:RXO – Get Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.44 billion. RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.RXO’s revenue was up 34.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.05 earnings per share. Equities research analysts predict that Rxo Inc will post 0.31 earnings per share for the current year.
Institutional Trading of RXO
Analyst Ratings Changes
A number of research firms recently commented on RXO. Zacks Research cut RXO from a “hold” rating to a “strong sell” rating in a report on Thursday, November 6th. UBS Group dropped their price objective on RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of RXO in a report on Wednesday, October 8th. Barclays reduced their target price on shares of RXO from $17.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. Finally, JPMorgan Chase & Co. lifted their target price on RXO from $15.00 to $16.00 and gave the company an “underweight” rating in a research report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $16.69.
Check Out Our Latest Analysis on RXO
About RXO
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More
- Five stocks we like better than RXO
- ETF Screener: Uses and Step-by-Step Guide
- Occidental Petroleum is a Buy in Q4 2025
- How to Use the MarketBeat Stock Screener
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Short Selling – The Pros and Cons
- Amazon Is One of the Clearest Buys If the Market Dips Again
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
